JAC Advance Access originally published online on March 16, 2005
Journal of Antimicrobial Chemotherapy 2005 55(5):764-767; doi:10.1093/jac/dki092
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Antimicrobial practice |
Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone
Outpatient and Home Parenteral Antibiotic Service, Brownlee Centre Infection Unit, Gartnavel General Hospital, 1053 Great Western Road, Glasgow G12 0YN, UK
* Corresponding author. Tel: +44-141-211-0292; Fax: +44-141-211-1097; Email: andrew.seaton{at}northglasgow.scot.nhs.uk
Objectives and methods: A management protocol for specialist nurses was developed for ambulatory management of uncomplicated cellulitis requiring initial intravenous (iv) antibiotic therapy. Patients were all managed through an outpatient parenteral antibiotic therapy (OPAT) service. Those with cellulitis were compared pre- and post-intervention.
Results: One hundred and fourteen patients were compared with 230 retrospective controls all managed through the OPAT service. Protocol management was associated with reduced duration of outpatient iv therapy from 4 to 3 days, P=0.02, and reduced need for physician review (100% to 19%). Outcomes, complications and readmissions were similar.
Conclusions: Specialist nurse-led management is safe and effective in the management of uncomplicated cellulitis in the context of an OPAT service and reduces the need for regular medical review without compromising clinical care.
Keywords: outpatient parenteral antibiotic therapy , intravenous antibiotic therapy , cellulitis , patient group direction , skin and soft tissue infections
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. L. N. Chapman, S. Dixon, D. Andrews, P. J. Lillie, R. Bazaz, and J. D. Patchett Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective J. Antimicrob. Chemother., December 1, 2009; 64(6): 1316 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Coenen, A. Muller, N. Adriaenssens, V. Vankerckhoven, E. Hendrickx, H. Goossens, and on behalf of the ESAC Project Group European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe J. Antimicrob. Chemother., July 1, 2009; 64(1): 200 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lamont, R. A. Seaton, M. Macpherson, L. Semple, E. Bell, and A. H. Thomson Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme J. Antimicrob. Chemother., July 1, 2009; 64(1): 181 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Seaton Daptomycin: rationale and role in the management of skin and soft tissue infections J. Antimicrob. Chemother., November 1, 2008; 62(suppl_3): iii15 - iii23. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gilchrist, B. D. Franklin, and J. P. Patel An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service J. Antimicrob. Chemother., July 1, 2008; 62(1): 177 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Matthews, C. P. Conlon, A. R. Berendt, J. Kayley, L. Jefferies, B. L. Atkins, and I. Byren Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years J. Antimicrob. Chemother., August 1, 2007; 60(2): 356 - 362. [Abstract] [Full Text] [PDF] |
||||
